MiniMed, German Firm to Develop Glucose Device
MiniMed Inc. in Sylmar has reached agreement with German-based Boehringer Mannheim Corp. to develop and market a new device to be used in hospitals to manage glucose levels in patients.
The device will be submitted to the U.S. Food and Drug Administration for approval.
MiniMed is a maker of infusion systems used primarily in the treatment of diabetes.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
